Equity Overview
Price & Market Data
Price: $0.49
Daily Change: +$0.01 / 2.04%
Range: $0.45 - $0.499
Market Cap: $48,182,436
Volume: 81,004
Performance Metrics
1 Week: -2.00%
1 Month: -11.38%
3 Months: -22.22%
6 Months: -32.97%
1 Year: -18.33%
YTD: -18.33%
Company Details
Employees: 85
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally. It offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis such as sepsis; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.